Peterson GM - Search Results

1

Evaluation of a chronic kidney disease risk assessment service in community pharmacies.

Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL. Gheewala PA, et al. Among authors: peterson gm. Nephrology (Carlton). 2019 Mar;24(3):301-307. doi: 10.1111/nep.13247. Nephrology (Carlton). 2019. PMID: 29493051

2

The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J. Krass I, et al. Diabet Med. 2007 Jun;24(6):677-83. doi: 10.1111/j.1464-5491.2007.02143.x. Diabet Med. 2007. PMID: 17523968 Clinical Trial.

3

Cardiovascular risk screening program in Australian community pharmacies.

Peterson GM, Fitzmaurice KD, Kruup H, Jackson SL, Rasiah RL. Peterson GM, et al. Pharm World Sci. 2010 Jun;32(3):373-80. doi: 10.1007/s11096-010-9379-8. Epub 2010 Mar 10. Pharm World Sci. 2010. PMID: 20217476

4

Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.

Williams M, Peterson GM, Tenni PC, Bindoff IK, Curtain C, Hughes J, Bereznicki LR, Jackson SL, Kong DC, Hughes JD. Williams M, et al. Among authors: peterson gm. Ann Pharmacother. 2011 Sep;45(9):1067-76. doi: 10.1345/aph.1Q138. Epub 2011 Aug 30. Ann Pharmacother. 2011. PMID: 21878658 Clinical Trial.

5

Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial.

Bernal DD, Stafford L, Bereznicki LR, Castelino RL, Davidson PM, Peterson GM. Bernal DD, et al. Among authors: peterson gm. Trials. 2012 Apr 2;13:30. doi: 10.1186/1745-6215-13-30. Trials. 2012. PMID: 22463733 Free PMC article. Clinical Trial.

6

Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management.

Bereznicki BJ, Peterson G, Jackson S, Walters EH, George J, Stewart K, March GJ. Bereznicki BJ, et al. J Clin Pharm Ther. 2013 Jun;38(3):212-8. doi: 10.1111/jcpt.12017. Epub 2013 Feb 26. J Clin Pharm Ther. 2013. PMID: 23437933 Clinical Trial.

7

Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?

Khanal A, Castelino RL, Peterson GM, Jose MD. Khanal A, et al. Among authors: peterson gm. Intern Med J. 2014 Jan;44(1):77-85. doi: 10.1111/imj.12291. Intern Med J. 2014. PMID: 24112311

8

Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?

Huang W, Castelino RL, Peterson GM. Huang W, et al. Among authors: peterson gm. Intern Med J. 2014 Mar;44(3):266-72. doi: 10.1111/imj.12369. Intern Med J. 2014. PMID: 24405767

9

Renal drug dosing recommendations: evaluation of product information for brands of the same drug.

Khanal A, Peterson GM, Castelino RL, Jose MD. Khanal A, et al. Among authors: peterson gm. Intern Med J. 2014 Jun;44(6):591-6. doi: 10.1111/imj.12446. Intern Med J. 2014. PMID: 24946814

10

Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities.

Gheewala PA, Peterson GM, Curtain CM, Nishtala PS, Hannan PJ, Castelino RL. Gheewala PA, et al. Among authors: peterson gm. Drugs Aging. 2014 Nov;31(11):825-35. doi: 10.1007/s40266-014-0208-y. Drugs Aging. 2014. PMID: 25187228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters